arformoterol tartrate inhalation

Generic: arformoterol tartrate inhalation

Labeler: slate run pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name arformoterol tartrate inhalation
Generic Name arformoterol tartrate inhalation
Labeler slate run pharmaceuticals
Dosage Form SOLUTION
Routes
RESPIRATORY (INHALATION)
Active Ingredients

arformoterol tartrate 15 ug/2mL

Manufacturer
Slate Run Pharmaceuticals

Identifiers & Regulatory

Product NDC 70436-151
Product ID 70436-151_3bd6ebed-0405-445a-8613-ae20b2e70703
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213762
Listing Expiration 2026-12-31
Marketing Start 2021-06-22

Pharmacologic Class

Classes
adrenergic beta2-agonists [moa] beta2-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70436151
Hyphenated Format 70436-151

Supplemental Identifiers

RxCUI
668956
UNII
5P8VJ2I235

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name arformoterol tartrate inhalation (source: ndc)
Generic Name arformoterol tartrate inhalation (source: ndc)
Application Number ANDA213762 (source: ndc)
Routes
RESPIRATORY (INHALATION)
source: ndc

Resolved Composition

Strengths
  • 15 ug/2mL
source: ndc
Packaging
  • 30 POUCH in 1 CARTON (70436-151-57) / 1 VIAL in 1 POUCH (70436-151-19) / 2 mL in 1 VIAL
  • 15 POUCH in 1 CARTON (70436-151-58) / 4 VIAL in 1 POUCH (70436-151-20) / 2 mL in 1 VIAL
source: ndc

Packages (2)

Ingredients (1)

arformoterol tartrate (15 ug/2mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "3bd6ebed-0405-445a-8613-ae20b2e70703", "openfda": {"unii": ["5P8VJ2I235"], "rxcui": ["668956"], "spl_set_id": ["7d639762-091b-471e-9355-c2f4737676a2"], "manufacturer_name": ["Slate Run Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 CARTON (70436-151-57)  / 1 VIAL in 1 POUCH (70436-151-19)  / 2 mL in 1 VIAL", "package_ndc": "70436-151-57", "marketing_start_date": "20210622"}, {"sample": false, "description": "15 POUCH in 1 CARTON (70436-151-58)  / 4 VIAL in 1 POUCH (70436-151-20)  / 2 mL in 1 VIAL", "package_ndc": "70436-151-58", "marketing_start_date": "20210622"}], "brand_name": "Arformoterol Tartrate Inhalation", "product_id": "70436-151_3bd6ebed-0405-445a-8613-ae20b2e70703", "dosage_form": "SOLUTION", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "70436-151", "generic_name": "Arformoterol Tartrate Inhalation", "labeler_name": "Slate Run Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Arformoterol Tartrate Inhalation", "active_ingredients": [{"name": "ARFORMOTEROL TARTRATE", "strength": "15 ug/2mL"}], "application_number": "ANDA213762", "marketing_category": "ANDA", "marketing_start_date": "20210622", "listing_expiration_date": "20261231"}